Download PDF
Aktuelle Urol 2012; 43(2): 102-103
DOI: 10.1055/s-0031-1284001
Uroonkologie
© Georg Thieme Verlag KG Stuttgart · New York

Praxisrelevante Informationen für den Umgang mit Portsystemen

Practical Information on the Use of Port Systems
J. Göckschu
1   Asklepios Klinik Altona, Abteilung für Urologie, Hamburg
,
M. Linbecker
1   Asklepios Klinik Altona, Abteilung für Urologie, Hamburg
,
C. Wülfing
1   Asklepios Klinik Altona, Abteilung für Urologie, Hamburg
› Author Affiliations
Further Information

Publication History

Publication Date:
27 March 2012 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

Durch die dynamische Entwicklung der Onkologie in den letzten Jahren stehen zur Behandlung von Krebspatienten in nahezu allen Tumorstadien multimodale Therapieoptionen zur Auswahl. Dies hat zu einer Zunahme der Chemotherapien geführt. Die niedrig- und mittelgradig komplexen Chemotherapien werden zunehmend in ambulanten und tagesklinischen Settings appliziert. Nicht zuletzt deshalb hat sich die Implantation von zentralvenösen Portsystemen zu einem wichtigen Bestandteil in der Therapieplanung von onkologischen Patienten entwickelt.

Abstract

As a result of the dynamic developments in oncology over the last few years, multimodal therapeutic options are now available for the treatment of cancer patients in practically all diseases stages. This has led to an increase in the use of all forms of chemotherapy. Low and moderately complex chemotherapy options are being increasingly employed in outpatient and day clinic settings. For this reason, among others, the implantation of central venous port systems has progressed to become an important component in the therapeutic planning for oncological patients.

Schlüsselwörter

Uroonkologie - multimodale Therapieoptionen - Chemotherapie

Key words

urooncology - multimodal therapeutic options - chemotherapy
 

  • Literatur

  • 1 Teichgräber UKM, Kausche S, Nagel SN et al. Outcome analysis in 3160 implantations of radiologically guided placements of totally implantable central venous port systems. Eur Radiol 2010; 21: 1224-1232
    PubMedGoogle Scholar
  • 2 Schenck M, Schneider T, Rübben H et al. Central venous port implantations via the cephalic vein applying an intravasal electrographic control of the catheter tip position: a single-center experience of 316 cases. 2011 DOI: 10.1007/s00345-011-0752-6
    PubMedGoogle Scholar
  • 3 Yldrm ÖzdemirN, Abal H, Öksüzolu B. It appears to be safe to start chemotherapy on the day of implantation through subcutaneous venous port catheters in inpatient setting. Support Care Cancer 2009; 17: 399-403
    CrossrefPubMedGoogle Scholar
  • 4 Vesica S, Baumgärtner AK, Jacobs VR et al. Management of venous port systems in oncology: a review of current evidence. Ann Oncol 2008; 19: 9-15
    PubMedGoogle Scholar
  • 5 Caers J, Fontaine C, Vinh-Hung V et al. Catheter tip position as a risk factor for thrombosis associated with the use of subcutaneous infusion ports. Support Care Cancer 2005; 13: 325-331
    CrossrefPubMedGoogle Scholar
  • 6 Wu P-Y, Yeh Y-C, Huang C-H et al. Spontaneous Migration of a Port-A-Cath Catheter into Ipsilateral Jugular Vein in Two Patients with Severe Cough. Ann Vasc Surg 2005; 19: 734-736
    CrossrefPubMedGoogle Scholar
  • 7 Schumacher M, Wagner RH. Central venous port system associated thromboses: outcome in 3498 implantations and literature review. Ger Med Sci 2007; 5 Doc 06
    PubMedGoogle Scholar